Alexithymia, Migraine
Conditions
Brief summary
The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity of the clinical phenotype of migraine, favoring its chronicization), in an analysis adjusted for psychiatric comorbidity (for anxiety and depression, potentially influencing migraine chronicization) and for personalogical factor represented by apathy.
Interventions
None listed
Sponsors
Azienda Sanitaria Locale di Alessandria
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
12 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of episodic migraine with or without aura, chronic migraine and/or MOH according to ICHD-3 2018 criteria; * Patients aged 12-65 years; * Female patients
Exclusion criteria
* Ongoing major depressive episode; * Comorbidities for major internal diseases (hepatopathy, nephropathy, heart failure, etc.); * Alcohol or substance abuse disorder (eoin, cocaine, cannabis, hallucinogens); * Language barrier; * Low cultural/cognitive level; * No informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Degree of alexithymia | In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval | Independent variable measured as a score on the TAS-20 scale |
| Migraine frequency | In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of drug days in patients diagnosed with MOH | In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval |
| Degree of alessithymia in patients diagnosed with MOH | In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval |
Countries
Italy
Outcome results
None listed